Your browser doesn't support javascript.
loading
A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic.
Prochaska, Judith J; Vogel, Erin A; Chieng, Amy; Baiocchi, Michael; Maglalang, Dale Dagar; Pajarito, Sarah; Weingardt, Kenneth R; Darcy, Alison; Robinson, Athena.
Affiliation
  • Prochaska JJ; Stanford Prevention Research Center, Department of Medicine, Stanford University, USA. Electronic address: jpro@stanford.edu.
  • Vogel EA; Stanford Prevention Research Center, Department of Medicine, Stanford University, USA.
  • Chieng A; Stanford Prevention Research Center, Department of Medicine, Stanford University, USA.
  • Baiocchi M; Department of Epidemiology & Population Health, School of Medicine, Stanford University, USA.
  • Maglalang DD; Stanford Prevention Research Center, Department of Medicine, Stanford University, USA.
  • Pajarito S; Woebot Health, USA.
  • Weingardt KR; Woebot Health, USA.
  • Darcy A; Woebot Health, USA.
  • Robinson A; Woebot Health, USA.
Drug Alcohol Depend ; 227: 108986, 2021 10 01.
Article in En | MEDLINE | ID: mdl-34507061

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Substance-Related Disorders / COVID-19 Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Drug Alcohol Depend Year: 2021 Document type: Article Country of publication: Ireland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Substance-Related Disorders / COVID-19 Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Drug Alcohol Depend Year: 2021 Document type: Article Country of publication: Ireland